Sign in
Not yet taking people in United StatesNo phase

A Behavioral Application for Improving Smoking Cessation Among Smokers

Key facts

Who runs it
Fred Hutchinson Cancer Center
Where
Seattle, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
1,812 people, planned
Started
1 Nov 2026
Expected to end
31 Jul 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Smartphone app-based Intervention (Actify! A app)
  • Smartphone app-based Intervention (Actify! B app)
  • Health Promotion and Education
  • Survey Administration
Record updated
12 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (23)Hide the full registry criteria

Who can take part

  • Age 18 or older
  • Currently smoke, averaging at least 5 cigarettes/day for the last 30 days
  • Interested in quitting smoking in the next 30 days
  • Experience downloading and using one or more apps on their smartphone
  • Either screens negative for depression (Patient Health Questionnaire - 9 item [PHQ-9] score 0-4; n = 906) or screens positive for mild to moderately severe current depressive symptoms (PHQ-9 score 5-19; n = 906)
  • Willing and able to complete all study activities and to receive compensation by mail
  • Comfortable reading and writing in English
  • Have a mobile data plan and/or access to WiFi to support the use of the assigned app
  • Reside in the United States (US)
  • Willing to provide information for an emergency contact in case of serious concerns about the participant's physical or mental health

Who cannot take part

  • Self-report of currently receiving behavioral treatment for depression (e.g., psychotherapy or counseling, web- or app-based interventions); current use of pharmacotherapy for depression or for other mental health conditions that are not otherwise excluded is allowable (e.g., benzodiazepines, anticonvulsants, opioid agonists, antipsychotics)
  • Currently receiving other smoking cessation treatments, including pharmacotherapies (nicotine replacement therapy, bupropion, or varenicline) and behavioral interventions (e.g. quitline counseling, other digital health programs), but excluding electronic (e)-cigarettes/vaping
  • Previous use of the QuitGuide program
  • Having a Google voice number as their primary phone number (due to association with fraudulent study entry attempts in our previous work)
  • History of a suicide attempt
  • Self-reported lifetime diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, antisocial personality disorder, or borderline personality disorder; or self-reported lifetime diagnosis of an alcohol or drug use disorder with use of the substance(s) in the past 30 days
  • Severe depression (PHQ-9 ≥ 20)
  • Current suicidal ideation reported on the PHQ-9
  • Employees/family of investigator or study center
  • Member of the same household as another participant
  • Woman who is pregnant or breastfeeding, or planning to become pregnant
  • Currently incarcerated
  • Participated in earlier studies to develop the Actify! app

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Cigarette smoking-related carcinoma

Where in United States

  • Fred Hutch/University of Washington Cancer ConsortiumSeattle, United StatesContact: Jaimee Heffner, PhDNot yet recruiting

About the trial

What the trial wants to find out

This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behaviors such as smoking. The Actify! B app provides evidence-based tobacco cessation strategies based on current clinical guidelines.

The 2 groups in the trial

  • Arm I (Actify! A app)Treatment being tested

    Participants use the Actify! app, which helps users identify personal values and meaningful activities, prompts users to schedule and complete meaningful activities, visualizes progress towards meeting activity and smoking-related goals, and provides tailored messages, resources, daily tips, personalized feedback, inspirational messages, and user stories, for 8 weeks on study.

    Treatment: Smartphone app-based Intervention (Actify! A app), Health Promotion and Education, and Survey Administration

  • Arm II (Actify! B app)Existing treatment, for comparison

    Participants use an app, which contains quit advice, tools for tracking smokefree days, progress and cravings, guidance on preparing to quit, managing cravings and withdrawal, recovering from slips, and a mood management feature, for 8 weeks on study.

    Treatment: Smartphone app-based Intervention (Actify! B app), Health Promotion and Education, and Survey Administration

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Actify! An mHealth Mood Management Tool to Improve Population-Level Smoking Cessation
Criteria questions
Built from NCT07493252, who can take part
Record updated
12 August 2026